Tharimmune’s $545 Million Initiative Speeds Up Blockchain Integration Among Institutions
- Tharimmune raised $545M via private placement led by DRW/Liberty City to build a Canton Coin treasury and develop institutional blockchain applications. - Funds will acquire Canton Coins, operate Super Validator nodes, and expand the Canton Network connecting Goldman Sachs , BNP Paribas, and DTCC. - Stock surged 120% post-announcement as Canton Foundation's first public investment and institutional backing from Deutsche Bank/HSBC highlight blockchain adoption trends. - Strategic leadership changes and $3
Tharimmune, Inc. (NASDAQ: THAR) has finalized a $545 million private funding round to launch a digital asset treasury plan focused on Canton Coin, the utility token that supports the Canton Network blockchain, as detailed in a
The raised funds will be used for Tharimmune’s purchase of Canton Coins, its responsibilities as a Super Validator on the Canton Network, and the creation of institutional-grade applications, as noted by Investing.com. In its Super Validator role, the company will run extra nodes to earn token incentives and boost network efficiency, according to a
Tharimmune’s entry into digital assets represents one of the largest institutional treasury deals so far, Cointelegraph reported. The company named Mark Wendland, previously DRW’s COO, as CEO to lead this initiative, while Mark Toomey from Liberty City Ventures has become President, per Morningstar. The current leadership team will remain in charge of Tharimmune’s biotech business, which specializes in treatments for inflammation and immune system disorders, The Block reported.
The Canton Foundation’s involvement in this funding round is its first investment in a publicly listed firm, The Block noted. DRW and Liberty City Ventures will allocate part of their investment directly into Canton Coins, which are not yet available on exchanges, according to an
This initiative reflects a wider movement in tokenized finance, where real-world assets (RWAs) now surpass $34.6 billion in value, including $18.4 billion in private credit and $8.7 billion in U.S. Treasury securities, as explored in a
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cardano News Update: Authorities and Blockchain Collaborate to Strengthen Compliance in the Evolving Crypto Landscape
- Chainlink partners with Apex Group and Bermuda's BMA to pilot institutional-grade stablecoin infrastructure with real-time regulatory oversight. - The framework enables on-chain compliance enforcement through CCIP, ACE, and Proof of Reserve, supported by $3.5T-asset custodian and security partners. - Cardano's ADA shows technical indicators suggesting a potential $0.80 breakout to $1.70, driven by x402 AI payment integration and bullish trader sentiment. - TrueBlue reports mixed Q3 results with 13% reven
XRP Update Today: Clear Regulations and Growing Institutional Interest Drive Major Crypto Advancements in 2025
- XRP's SEC lawsuit resolution clears path for spot ETFs, with Bitwise and Grayscale launching 0.34-0.35% fee products within weeks. - AVAX gains institutional traction via $638M tokenized Treasurys and Wyoming/Japan government partnerships, with $20.15 support critical for $85–$135 rebound. - MoonBull ($MOBU) targets 9,256% ROI through 23-stage presale, leveraging Ethereum security and 95% APY staking to outpace meme coin rivals. - 2025 crypto outlook hinges on XRP ETF adoption, AVAX's technical resilienc
Combating Obesity: Trump’s Pharmaceutical Agreement Cuts Costs for Millions
- Trump administration secures $350-$149/month price cuts for GLP-1 drugs via TrumpRx.gov, expanding Medicare/Medicaid coverage to 40% of obese Americans. - Lilly and Novo Nordisk commit to aligning U.S. pricing with global benchmarks under MFN framework, part of broader cost-control measures including FDA incentives. - Policy faces $35B annual deficit risks from high demand, while pharma firms gain tariff certainty and access to 60M+ beneficiaries previously excluded. - Market reacts cautiously as Novo sh
Blockchain Joins Wall Street: RTB Digital Integrates Media and Payments in Bid for NASDAQ
- RYVYL and Roundtable merge to form RTB Digital, Inc., targeting a NASDAQ listing by integrating blockchain media and digital payment solutions. - Aly Madhavji, a seasoned Web3 investor and CFO, brings 30+ years of finance and blockchain expertise to the merged entity. - The new entity retains the "Roundtable" brand under CEO James Heckman, with leadership including DeFi pioneers and strategic partners. - The merger faces regulatory hurdles and integration challenges, with forward-looking statements cauti
